Phase I Trial of Weekly MK-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study

PURPOSE: Amplification and high-levels of NOTCH ligand expression have been identified in several types of pediatric brain tumors. A phase I trial of weekly MK-0752, an oral inhibitor of gamma-secretase, was conducted in children with recurrent central nervous system (CNS) malignancies to estimate t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Childs Nerv Syst
Autori principali: Hoffman, Lindsey M., Fouladi, Maryam, Olson, James, Daryani, Vinay M., Stewart, Clinton F., Wetmore, Cynthia, Kocak, Mehmet, Onar-Thomas, Arzu, Wagner, Lars, Gururangan, Sridharan, Packer, Roger J., Blaney, Susan M., Gajjar, Amar, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681692/
https://ncbi.nlm.nih.gov/pubmed/25930724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00381-015-2725-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi